General company profile

Rescop was founded in 2005 by two corporate auditors. After working several years for a large international pharmaceutical company, they decided to combine their strengths to develop innovative solutions for compliance with GxP regulations. The reason for the founding of Rescop is the development and implementation of Compliance & Quality Management Software. These products are developed by a team of validation engineers and IT auditors on the one hand, and highly educated, certified and experienced software developers on the other hand.

Company activities:

GxP compliance service & solutions:
- qualification & validation
- quality management
- auditing & assessment
- FDA remediation
- academy services
- paperless validation

We are looking for

Validation consultants / engineers, GxP or Computerized system validation.


- Professional level of verbal and writing skills (English and preferably the language of the country of assignment)
- Bachelor or master’s degree in Life Sciences or comparable
- Knowledge of regulations, quality standards and a GxP mindset
- A minimum of 2 years of experience with compliance, in life science industry or an industry with a comparable high regulatory level, is required
- Competent in MS Office products and experience with Quality Systems

What we have to offer

Rescop offers a challenging position in a fast growing international environment where we invest in the personal development of our employees. We create opportunity for professional development, career growth, autonomy, strong rewarding and community impact.

Company info

Verlengde Poolseweg 6
4818 CL Breda
Name contactperson
Werner Luining
Phone number
Number of locations:
Number of employees
Active in sectors
Bio/Life Sciences, Pharma
Type of organisation

Create a job alert

Would you like to receive the latest vacancies in your e-mail box? Create a job alert based on your keyword(s) and preferences.

Sign up

Hyphen Projects uses cookies to remember certain preferences and align interests.
By continuing to use this site, you consent to our use of cookies.